Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Innate immune regulatory networks in hepatic lipid metabolism
Lan Bai, Hongliang Li
Journal of Molecular Medicine (2019) Vol. 97, Iss. 5, pp. 593-604
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Ze Chen, Ruifeng Tian, Zhi‐Gang She, et al.
Free Radical Biology and Medicine (2020) Vol. 152, pp. 116-141
Open Access | Times Cited: 952
Nonalcoholic Fatty Liver Disease
Yan-Ci Zhao, Guojun Zhao, Ze Chen, et al.
Hypertension (2019) Vol. 75, Iss. 2, pp. 275-284
Open Access | Times Cited: 192
COVID‐19 and non‐alcoholic fatty liver disease: Two intersecting pandemics
Piero Portincasa, Marcin Krawczyk, Wiktor Smyk, et al.
European Journal of Clinical Investigation (2020) Vol. 50, Iss. 10
Open Access | Times Cited: 134
Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk
Agostino Di Ciaula, Jacek Baj, Gabriella Garruti, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2648-2648
Open Access | Times Cited: 127
Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application
Yu Xu, Wei Guo, Cheng Zhang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 113
Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease
Ze Chen, Yao Yu, Jingjing Cai, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 12, pp. 903-914
Closed Access | Times Cited: 105
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
Agostino Di Ciaula, Salvatore Passarella, Harshitha Shanmugam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5375-5375
Open Access | Times Cited: 94
TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
Dan Liu, Peng Zhang, Junjie Zhou, et al.
Cell Metabolism (2020) Vol. 31, Iss. 4, pp. 726-740.e8
Open Access | Times Cited: 82
Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia
Ze Chen, Jiayi Liu, Feng Zhou, et al.
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1747-1765
Open Access | Times Cited: 77
Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression
Marcello Dallio, Moris Sangineto, Mario Romeo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 436-436
Open Access | Times Cited: 58
High Remnant Cholesterol Level Potentiates the Development of Hypertension
Mingming Chen, Xuewei Huang, Chengsheng Xu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 39
COVID‐19 metabolism: Mechanisms and therapeutic targets
Tianshi Wang, Ying Cao, Haiyan Zhang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 35
Recent advances in age-related metabolic dysfunction-associated steatotic liver disease
Qianjun He, Yifei Li, Ling-Tong Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 7, pp. 652-662
Open Access | Times Cited: 7
The hepatic lipidome: From basic science to clinical translation
Marit ten Hove, L. V. Pater, Gert Storm, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 180-197
Open Access | Times Cited: 47
Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
Weiyi Qu, Tengfei Ma, Jingjing Cai, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 40
Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
Alexandra Jichitu, Simona Bungău, Ana Maria Alexandra Stănescu, et al.
Diagnostics (2021) Vol. 11, Iss. 4, pp. 689-689
Open Access | Times Cited: 37
Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses
Kazuma Mori, Marenao Tanaka, Itaru Hosaka, et al.
Hypertension Research (2023) Vol. 46, Iss. 5, pp. 1110-1121
Closed Access | Times Cited: 16
Graphene oxide nanoparticles induce hepatic dysfunction through the regulation of innate immune signaling in zebrafish (Danio rerio)
Guanghua Xiong, Yunyun Deng, Xinjun Liao, et al.
Nanotoxicology (2020) Vol. 14, Iss. 5, pp. 667-682
Closed Access | Times Cited: 35
Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease
Ke‐Qiong Deng, Xuewei Huang, Fang Lei, et al.
AJP Cell Physiology (2022) Vol. 323, Iss. 2, pp. C630-C639
Closed Access | Times Cited: 22
Association between dietary inflammation index and hypertension in participants with different degrees of liver steatosis
Wenhao Wu, Zhuoya Zhang, Qi Yan, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 11
Correlation between the triglyceride-glucose index and the onset of atrial fibrillation in patients with non-alcoholic fatty liver disease
Yao Zhang, Leigang Wang, Jiaxin Qi, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Association of steatotic liver disease with all-cause and cardiovascular mortality among prehypertensive or hypertensive patients
Shiwei Yan, Qian Li, Wenzhe Cao, et al.
Journal of Global Health (2025) Vol. 15
Closed Access
Impact of protein intake from a caloric-restricted diet on liver lipid metabolism in overweight and obese rats of different sexes
Ying Tian, Jian Gong, Zhiyan He, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Integrated transcriptomics and metabolomics uncover metabolites and pathways in American bullfrog (Aquarana catesbeiana) response to Elizabethkingia miricola infection
Peikui Yang, Jiawei Lin, Jude Juventus Aweya, et al.
Aquaculture (2025), pp. 742262-742262
Closed Access
Rationale for choosing antihypertensive therapy in a patient with NAFLD and arterial hypertension
С. Н. Мехтиев, O. A. Mekhtiyeva, O. M. Berko
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 86-95
Closed Access
Page 1 - Next Page

Scroll to top